Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 4, 1997, Pages 813-823

  Kievit, Els ^a   Van Gog, Frank B ^a   Schlüper, Hennie M M ^a   Van Dongen, Guus A M S ^a   Pinedo, Herbert M ^a   Boven, Epie ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

131I; 186Re; MAb 323 A3; Ovarian cancer xenografts; Radioimmunotherapy

Indexed keywords

MONOCLONAL ANTIBODY 323 A3; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; COLORECTAL CANCER; CONTRAST ENHANCEMENT; DOSIMETRY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; RADIOIODINATION; TUMOR DIAGNOSIS; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, NUDE; ORGANOTECHNETIUM COMPOUNDS; OVARIAN NEOPLASMS; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RHENIUM; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030859197     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00007-2     Document Type: Article

References (31)

1. 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice. Cancer Res. 51:676-681; 1991.
2. Breitz, H. B.; Weiden, P. L.; Vanderheyden, J. L.; Appelbaum, J. W.; Bjorn, M. J.; Fer, M. F.; Wolf, S. B.; Ratliff, B. A.; Seiler, C. A.; Foisie, D. C.; Fisher, D. R.; Schroff, R. W.; Fritzberg, A. R.; Abrams, P. G. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: Results of phase I trials. J. Nucl. Med. 33:1099-1112; 1992.
3. Chen, T. R.; Drabkowski, D.; Hay, R. J.; Macy, M.; Peterson, W. WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. Cancer Genet. Cytogenet. 27:125-134; 1987.
4. Crippa, F.; Bolis, G.; Seregni, E.; Gavoni, N.; Scarfone, G.; Ferraris, C.; Buraggi, G. L.; Bombardieri, E. Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv 18: Clinical results in patients with minimal residual disease of ovarian cancer. Eur. J. Cancer 31A:686-690; 1995.
5. Dilmann, L. T. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation. MIRD pamphlet No. 4. J. Nucl. Med. Suppl. 2:6-13; 1969.
6. Edwards, D. P.; Grzyb, K. T.; Dressler, L. G.; Mansel, R. E.; Zava, D. T.; Sledge, G. W.; McGuire, W. L. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Cancer Res. 46:1306-1317; 1986.
7. 99mTc-labeling of antibodies. Nucl. Med. 26:7-12; 1987.
8. Fritzberg, A. R.; Abrams, P. G.; Beaumier, P. L.; Kasina, S.; Morgan, A. C.; Rao, T. N.; Reno, J. M.; Sanderson, J. A.; Srinivasan, A.; Wilbur, D. S.; Vanderheyden, J. L. Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proc. Natl. Acad. Sci. USA 85:4025-4029; 1988.
9. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes. Br. J. Cancer. 66:1048-1052; 1992.
10. 186Relabeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts. Cancer. Res. 53:3524-3529; 1993.
11. Goldenberg, D. M.; Griffiths, G. L. Radioimmunotherapy of cancer: Arming the missiles. J. Nucl. Med. 33:1110-1112; 1992.
12. 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice. Cancer Res. 50:7973-7978; 1990.
13. Griffiths, G. L.; Goldenberg, D. M.; Diril, H.; Hansen, H. J. Technetium-99m, rhenium-186, and rhenium-188 direct-labeled antibodies. Cancer 73:761-768; 1994.
14. Hamilton, T. C.; Young, R. C.; McKoy, W. M.; Grotzinger, K. R.; Green, J. A.; Chu, E. W.; Whang-Peng, J.; Rogan, A. M.; Green, W. R.; Ozols, R. F. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43:5379-5389; 1983.
15. Hird, V.; Maraveyas, A.; Snook, D.; Dhokia, B.; Soutter, W. P.; Meares, C.; Stewart, J. S. W.; Mason, P.; Lambert, H. E.; Epenetos, A. A. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br. J. Cancer 68:403-406; 1993.
16. Jacobs, A. J.; Fer, M.; Su, F. M.; Breitz, H.; Thompson, J.; Goodgold, H.; Cain, J.; Heaps, J.; Weiden, P. A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: Toxicity and clinical response. Obstet. Gynecol. 82:586-593; 1993.
17. John, E.; Thakur, M. L.; Defulvio, J.; McDevitt, M. R.; Damjanov, I. Rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: Preparation and evaluation. J. Nucl. Med. 34:260-267; 1993.
18. Kievit, E.; Pinedo, H. M.; Schlüper, H. M. M.; Haisma, H. J.; Boven, E. Comparison of the monoclonal antibodies 17-1A and 323/A3: The influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts. Br. J. Cancer 73:457-464; 1996.
19. 131I-labeled antibody in multicell spheroids. Int. J. Radiat. Oncol. Biol. Phys. 24:127-132; 1992.
20. Lindmo, T.; Boven, E.; Cuttitta, F.; Fedorko, J.; Bunn, P. A. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods 72:77-89; 1984.
21. Litvinov, S. V.; Velders, M. P.; Bakker, H. A. M.; Fleuren, G. J.; Warnaar, S. O. Ep-CAM: A human epithelial antigen is a homophilic cell-cell adhesion molecule. J. Cell. Biol. 125:437-446; 1994.
22. Mello, A. M.; Pauwels, E. K. J.; Cleton, F. J. Radioimmunotherapy: No news from the newcomer. J. Cancer. Res. Clin. Oncol. 120:121-130; 1994.
23. Muthuswamy, M. S.; Roberson, P. L.; Ten Haken, R. K.; Buchsbaum, D. J. A quantitative study of radionuclide characteristics for radioimmunotherapy from 3D reconstructions using serial autoradiography. Int. J. Radiat. Oncol. Biol. Phys. 35:165-172; 1996.
24. 4 chelate in vitro and in vivo using tumor-bearing nude mice. Int. J. Radiat. Appl. Instrum. Part B:205-212; 1992.
25. O'Donoghue, J. A.; Bardies, M.; Wheldon, T. E. Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. J. Nucl. Med. 36:1902-1909; 1995.
26. 186Re-labeling of monoclonal antibodies. Cancer 73:769-773; 1994.
27. Simpkin, D. J.; Mackie, T. R. EGS4 Monte Carlo determination of the beta dose kernel in water. Med. Phys. 17:179-186; 1990.
28. Stewart, J. S. W.; Hird, V.; Snook, D.; Sullivan, M.; Hooker, G.; Courtenay-Luck, N.; Sivolapenko, G.; Griffiths, M.; Myers, M. J.; Lambert, H. E.; Munro, A. J.; Epenetos, A. A. Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of 1-131 labeled monoclonal antibodies. Int. J. Radiat. Oncol. Biol. Phys. 16:405-413; 1989.
29. Van Gog, F. B.; Visser, G. W. M.; Klok, R.; Van der Schors, R.; Snow, G. B.; Van Dongen, G. A. M. S. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: Relationship between the number of chelated groups and biodistribution characteristics. J. Nucl. Med. 37:352-362; 1996.
30. Visser, G. W. M.; Gerretsen, M.; Herscheid, J. D. M.; Snow, G. B.; Van Dongen, G. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: A technical protocol. J. Nucl. Med. 34:1953-1963; 1993.
31. Wessels, B. W.; Rogus, R. D. Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies. Med. Phys. 11:638-645; 1984.